HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/1/C192    most recent 00337.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Clarke, L. L. Articles by Price, E. M. Search for Related Content PubMed PubMed Citation Articles by Clarke, L. L. Articles by Price, E. M.

MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS

A domain mimic increases F508 CFTR trafficking and restores cAMP-stimulated anion secretion in cystic fibrosis epithelia

Departments of ¹Biomedical Sciences and ²Medical Physiology and Pharmacology and Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211

Submitted 5 August 2003 ; accepted in final form 10 March 2004

The major disease-causing mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) is deletion of phenylalanine 508 (F508), which adversely affects processing and plasma membrane targeting of CFTR. Under conditions predicted to stabilize protein folding, F508 CFTR is capable of trafficking to the plasma membrane and retains cAMP-regulated anion channel activity. Overexpression is one factor that increases CFTR trafficking; therefore, we hypothesized that expression of a domain mimic of the first nucleotide-binding fold (NBF1) of CFTR, i.e., the site of F508, may be sufficient to overwhelm the quality control process or otherwise stabilize F508 CFTR and thereby restore cAMP-stimulated anion secretion. In epithelial cells expressing recombinant F508 human (h)CFTR, expression of wild-type NBF1 increased the amount of both core-glycosylated and mature protein to a greater extent than expression of F508 NBF1. Expression of wild-type NBF1 in the F508 hCFTR cells increased whole cell Cl^– current density to 50% of that in cells expressing wild-type hCFTR. Expression of NBF1 in polarized epithelial monolayers from a F508/F508 cystic fibrosis mouse (MGEF) restored cAMP-stimulated transepithelial anion secretion but not in monolayers from a CFTR-null mouse (MGEN). Restoration of anion secretion was sustained in NBF1-expressing MGEF for >30 passages, whereas MGEN corrected with hCFTR progressively lost anion secretion capability. We conclude that expression of a NBF1 domain mimic may be useful for correction of the F508 CFTR protein trafficking defect in cystic fibrosis epithelia.

protein processing; mouse; retrovirus; gene therapy

This article has been cited by other articles:

				E. Cormet-Boyaka, J. S. Hong, B. K. Berdiev, J. A. Fortenberry, J. Rennolds, J. P. Clancy, D. J. Benos, P. N. Boyaka, and E. J. Sorscher A truncated CFTR protein rescues endogenous {Delta}F508-CFTR and corrects chloride transport in mice FASEB J, November 1, 2009; 23(11): 3743 - 3751. [Abstract] [Full Text] [PDF]

				F. Sun, Z. Mi, S. B. Condliffe, C. A. Bertrand, X. Gong, X. Lu, R. Zhang, J. D. Latoche, J. M. Pilewski, P. D. Robbins, et al. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia FASEB J, September 1, 2008; 22(9): 3255 - 3263. [Abstract] [Full Text] [PDF]